On Biotech Hot Streak, Roche Picks Up Arius

Law360, New York (July 23, 2008, 12:00 AM EDT) -- Roche Holdings AG continues its takeover streak, announcing plans Wednesday to purchase Arius Research Inc. for $189.3 million (CAD$191 million) and bringing its total of newly acquired North American biotechnology firms to three for this week.

The companies announced Wednesday that they had signed an agreement that would allow Roche to acquire Arius, a firm that develops biotherapeutics in the fields of oncology and inflammatory disease.

The deal will give Roche proprietary rights to FunctionFIRST, a platform that generates and selects therapeutic antibodies based on their...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.